Table 1:
Fixed Effects Variables Relationships with Pain Outcomes
| Outcome Predictors | B | 95% CI | SE | t-value | p-value | Cohen’s d |
|---|---|---|---|---|---|---|
| Pain Unpleasantness | ||||||
| Session* | −0.16 | [−0.29, −0.04] | 0.064 | −2.557 | .011 | −0.102 |
| Segmenta | 0.02 | [−0.10, 0.14] | 0.063 | 0.310 | .757 | 0.012 |
| Temperature* | 3.13 | [3.00, 3.26] | 0.065 | 48.328 | <.001 | 1.943 |
| Removal* | 1.22 | [0.83, 1.61] | 0.199 | 6.089 | <.001 | 0.242 |
| Trial | 0.008 | [−0.02, 0.04] | 0.014 | 0.610 | .542 | 0.025 |
| Age (in years)* | −0.05 | [−0.10, −0.01] | 0.023 | −2.315 | .023 | −0.442 |
| Genderb | −0.45 | [−1.61, 0.72] | 0.652 | −0.695 | .560 | −0.988 |
| Languagec | 0.01 | [−0.11, 0.14] | 0.065 | 0.206 | .837 | 0.008 |
| Cultural Dominance | −0.26 | [−0.73, 0.21] | 0.241 | −1.080 | .280 | −0.066 |
| Language x Cultural Dominance | −0.08 | [−0.36, 0.18] | 0.136 | −0.652 | .514 | −0.026 |
| Pain Intensity | ||||||
| Session* | −0.27 | [−0.39, −0.14] | 0.062 | −4.271 | <.001 | −0.171 |
| Segmenta | 0.04 | [−0.08, 0.16] | 0.062 | 0.632 | .527 | 0.025 |
| Temperature* | 3.10 | [2.98, 3.22] | 0.063 | 49.121 | <.001 | 1.975 |
| Removal* | 0.88 | [0.50 1.26] | 0.194 | 4.516 | <.001 | 0.180 |
| Trial | 0.004 | [−0.02, 0.03] | 0.013 | 0.327 | .744 | 0.013 |
| Age (in years)* | −0.05 | [−0.10, −0.01] | 0.022 | −2.488 | .014 | −0.473 |
| Genderb | −0.39 | [−1.22, 0.40] | 0.498 | −0.792 | .513 | −1.136 |
| Languagec | 0.06 | [−0.06, 0.19] | 0.063 | 1.021 | .307 | 0.041 |
| Cultural Dominance | 0.08 | [−0.37, 0.54] | 0.235 | 0.359 | .719 | 0.022 |
| Language x Cultural Dominance* | −0.46 | [−0.72, −0.20] | 0.132 | −3.442 | <.001 | −0.138 |
| Pain-Evoked Physiological Arousal (mSCRa) | ||||||
| Session* | −0.16 | [−0.21, −0.10] | 0.030 | −5.232 | <.001 | −0.216 |
| Segment*a | −0.30 | [−0.36, −0.24] | 0.029 | −10.307 | <.001 | −0.426 |
| Temperature* | 0.88 | [0.82, 0.94] | 0.030 | 29.567 | <.001 | 1.222 |
| Removal* | −0.24 | [−0.42, −0.07] | 0.089 | −2.741 | .006 | −0.112 |
| Trial* | −0.08 | [−0.10, −0.07] | 0.006 | −12.994 | <.001 | −0.538 |
| Age (in years)* | −0.05 | [−0.07, −0.03] | 0.010 | −4.443 | <.001 | −0.839 |
| Genderb | 0.19 | [−0.22, 0.60] | 0.199 | 0.971 | .335 | 0.227 |
| Languagec | 0.03 | [−0.03, 0.09] | 0.030 | 0.946 | .344 | 0.039 |
| Cultural Dominance | −0.06 | [−0.27, 0.15] | 0.109 | −0.539 | .590 | −0.032 |
| Language x Cultural Dominance* | −0.16 | [−0.28, −0.04] | 0.062 | −2.657 | .008 | −0.110 |
Variables with significant (p <.05) slopes.
Segment denotes comparison between pre-priming and post-priming trials, with negative values corresponding to higher pain outcomes pre-priming.
Negative values for gender denote higher pain outcomes in women.
Language coded as 0 for English, 1 for Spanish; negative values denote higher pain outcomes in English. B-slope, CI- Confidence Interval, SE-Standard Error, mSCRa- mean skin conductance response amplitude.